NC
SILK

nVerses Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

nVerses Capital’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,600
Closed -$29.3K – 1250
2024
Q1 		$29.3K Buy
+1,600
New +$25.4K 0.07% 348

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

nVerses Capital's SILK Position: Q2 2024 in Review

nVerses Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 1,600 shares — an estimated $29.3K sold.

nVerses Capital first reported a position in SILK in Q1 2024 and held it in 1 quarter. The position peaked at $29.3K in Q1 2024. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • nVerses Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • nVerses Capital sold 1,600 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $29.3K.
  • nVerses Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • nVerses Capital's Silk Road Medical, Inc. Common Stock position peaked at $29.3K in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.